JPWO2022037527A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022037527A5
JPWO2022037527A5 JP2023509554A JP2023509554A JPWO2022037527A5 JP WO2022037527 A5 JPWO2022037527 A5 JP WO2022037527A5 JP 2023509554 A JP2023509554 A JP 2023509554A JP 2023509554 A JP2023509554 A JP 2023509554A JP WO2022037527 A5 JPWO2022037527 A5 JP WO2022037527A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
acid sequence
variable domain
single variable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023509554A
Other languages
English (en)
Japanese (ja)
Other versions
JP7821159B2 (ja
JP2023537958A5 (https=
JP2023537958A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/112756 external-priority patent/WO2022037527A1/zh
Publication of JP2023537958A publication Critical patent/JP2023537958A/ja
Publication of JPWO2022037527A5 publication Critical patent/JPWO2022037527A5/ja
Publication of JP2023537958A5 publication Critical patent/JP2023537958A5/ja
Application granted granted Critical
Publication of JP7821159B2 publication Critical patent/JP7821159B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023509554A 2020-08-20 2021-08-16 Ｂｃｍａと結合する単一可変ドメイン及び抗原結合分子 Active JP7821159B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202010842370 2020-08-20
CN202010842370.5 2020-08-20
PCT/CN2021/112756 WO2022037527A1 (zh) 2020-08-20 2021-08-16 结合bcma的单可变结构域及抗原结合分子

Publications (4)

Publication Number Publication Date
JP2023537958A JP2023537958A (ja) 2023-09-06
JPWO2022037527A5 true JPWO2022037527A5 (https=) 2024-08-26
JP2023537958A5 JP2023537958A5 (https=) 2024-08-26
JP7821159B2 JP7821159B2 (ja) 2026-02-26

Family

ID=80323410

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023509554A Active JP7821159B2 (ja) 2020-08-20 2021-08-16 Ｂｃｍａと結合する単一可変ドメイン及び抗原結合分子

Country Status (5)

Country Link
EP (1) EP4202047A4 (https=)
JP (1) JP7821159B2 (https=)
KR (1) KR20230045066A (https=)
CN (1) CN115715325A (https=)
WO (1) WO2022037527A1 (https=)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4282877A3 (en) 2016-08-10 2024-02-21 Legend Biotech Ireland Limited Chimeric antigen receptors targeting bcma and methods of use thereof
BR112020006248A8 (pt) * 2017-09-29 2023-03-21 Mogam Inst Biomedical Res Anticorpo anti-bcma com alta afinidade para bcma, polinucleotídeo, vetor de expressão, célula hospedeira, método para produção do dito anticorpo, composição farmacêutica compreendendo o mesmo e uso do anticorpo para prevenção ou tratamento de câncer
UY38251A (es) * 2018-06-01 2019-12-31 Novartis Ag Moléculas de unión contra bcma y usos de las mismas
EP3845244A4 (en) * 2018-08-24 2022-09-07 Shenzhen Pregene Biopharma Co. Ltd. ANTI-BCMA SINGLE DOMAIN ANTIBODIES AND THEIR USE
CN109942708B (zh) * 2019-03-28 2021-01-05 上海科棋药业科技有限公司 一种抗bcma的单域抗体及其应用
CN109942709B (zh) * 2019-04-22 2019-12-27 广州百暨基因科技有限公司 一种抗bcma的单域抗体及其应用
CN111333729B (zh) * 2020-03-17 2022-12-06 深圳市南科生物工程有限公司 抗b细胞成熟抗原的纳米抗体及应用
CN117062840A (zh) * 2021-04-15 2023-11-14 正大天晴药业集团股份有限公司 靶向bcma的多特异性抗体

Similar Documents

Publication Publication Date Title
CN102421802B (zh) 人源化的axl抗体
JP2020525032A5 (https=)
JP2019536430A5 (https=)
JP2020506898A5 (https=)
CN111201238B (zh) 产生多特异性抗体混合物及其使用方法
JP2024062992A5 (https=)
WO2020114478A1 (zh) Cd3抗体及其药物用途
JPWO2020069028A5 (https=)
JP2020508997A5 (https=)
JP2011509245A5 (https=)
JP2020516309A5 (https=)
RU2010100638A (ru) Композиции и способы лечения, направленные против cd20
HRP20120701T1 (hr) Humana monoklonska protutijela protiv fukozil-gm1 i postupci za uporabu antifukozil-gm1
WO2015146437A1 (ja) 高機能性ＩｇＧ２型二重特異性抗体
JP2012526558A5 (https=)
JP2018526981A5 (https=)
CN108136012A (zh) 靶向分子的抗原结合构建体
JP2021522303A5 (https=)
WO2019196309A1 (zh) 抗pd-l1抗体及其用途
JPWO2020059847A5 (https=)
CN118076387A (zh) 靶向表达cdh17的肿瘤的多特异性抗体及其制备和使用方法
JP2020513759A5 (https=)
JP2026510999A (ja) Ｃｄ１９／ｃｄ３８多重特異性抗体
JP2020531003A5 (https=)
CN115698077A (zh) 结合bcma的单可变结构域及抗原结合分子